Navigation Links
Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development
Date:9/2/2010

CARY, N.C., Sept. 2 /PRNewswire/ -- Cetero Research, the leading early-stage contract research organization (CRO), is launching a series of scientific seminars, "An Accelerated Path to Proof-of-Concept in Drug Development," designed to help pharmaceutical and biotechnology researchers learn the latest innovations in Phase I and IIa clinical trial designs. The sessions will familiarize attendees with techniques and study designs to save time and money when bringing new drugs to market. The seven-city series starts on September 15 in Princeton, N.J., and ends on October 21 in San Diego.

"We know that pharmaceutical and biotechnology companies are under increased pressure to get drugs to market as soon as possible. Identifying viable drug candidates quickly allows resources to be used more strategically," said Dr. Troy McCall, CEO of Cetero Research. "Through this seminar series, we can share our expertise and best practices in accelerating the drug development process. Some of the techniques we will be discussing have been shown to cut clinical trial timelines in half and reduce costs by more than 10 percent."

The seminars will focus on three topics: combined Phase I and IIa studies to accelerate proof-of-concept, biomarker fit-for-purpose assays and advanced population PK/PD modeling/analysis. Industry experts will share information and real-life case studies about the accelerated proof-of-concept (AcPOC) study designs and how to select the appropriate level of validation for biomarker assays to ensure that studies meet the current guidance. In addition, Cetero executives will discuss lessons learned from conducting more than 10,000 clinical pharmacology studies in a range of therapeutic areas, working with both healthy participants and patient populations.

"Our case studies demonstrate how the AcPOC study design can combine multiple trials – including single ascending dose (SAD), multiple ascending dose (MAD), preliminary interaction
'/>"/>

SOURCE Cetero Research
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cetero Research Leads Industry in Human Allergy Models
2. St. Jude Childrens Research Hospital Doctors and Scientists Team up to Fight Childhood Cancer
3. Bend Research Receives Patent for Preparing Spray-Dried Drug Dispersions Using Pressure Nozzles
4. Society of Interventional Radiology Supports Research for New M.S. Treatments
5. NeoStem Comments on Recent Court Ruling Blocking the Federal Governments Funding of Embryonic Stem Cell Research
6. Embryonic Stem Cell Research in the Toilet, According to Arthritis Treatment Center
7. Preliminary Research Results Suggest up to 70% Reduction in Dose for Positron Emission Mammography Imaging
8. International Research Team Closes In On Cause of Common Form of Muscular Dystrophy
9. Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets
10. CVS Caremark Behavioral Change Research Partnership Presents Ongoing Research at Center for Disease Control Symposium
11. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014  Today DePuy Synthes Companies ... angle plating systems featuring its proprietary variable angle ... screw trajectory to match patient anatomy and fracture ... bone. The systems are being introduced in conjunction ... (AOFAS) and the International Federation of Foot & ...
(Date:9/19/2014)... /PRNewswire-iReach/ -- Market Research Report on Global ... a professional and in-depth market survey on ... report firstly reviews the basic information of ... manufacturing technology. The report then explores global ... listing their product specification, capacity, Production value, ...
(Date:9/19/2014)... 19, 2014 Research ... the addition of the "Global Gynecological ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... classified into wide categories based on their ... treatment of different gynecological conditions that affect ...
Breaking Medicine Technology:DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3
... March 5, 2012   Synteract , Inc., a full-service contract ... MBA, as senior vice president of sales and marketing and ... president, global project management, to support growth in the company ... Barr, COO Stewart Bieler, and CFO Patrik Jeanmonod on the ...
... Checkpoint Surgical has received the CE mark ... intraoperative neuroprotective stimulator that helps surgeons locate, identify ... to facilitate nerve preservation and repair. ... certification demonstrates that a medical device meets rigorous ...
Cached Medicine Technology:Synteract Expands Executive Roles to Support Growth 2Synteract Expands Executive Roles to Support Growth 3Checkpoint Surgical Receives CE Mark 2
(Date:9/21/2014)... Over the past five years, the patent ... market, thereby cutting into revenue growth for the ... from Industry Canada, the loss of patent protection for ... billion in 2010 and 2012, respectively. “In response to ... hampered revenue growth, many pharmaceutical manufacturers have streamlined their ...
(Date:9/21/2014)... metastasize? Think of Sparta. , Ancient Greek warriors were ... the demands of battle on distant fields. Cancer cells ... a new study revealing previously unknown differences between cancer ... site, and those that travel to other organs. , ... is the primary cause of cancer-related death, understanding how ...
(Date:9/21/2014)... 2014 Hundreds of Risperdal lawsuits ... Pennsylvania’s Philadelphia Court of Common Pleas, Bernstein Liebhard ... next monthly meeting has been scheduled for October ... “Our Firm is representing a number of plaintiffs ... We are pleased with its continued progress,” says ...
(Date:9/21/2014)... Cheap Hosting USA, one of the leading review websites, ... the best Reseller hosting suppliers in 2014. “It is ... these companies have outperformed their competitors on hosting features, ... the best web hosting at affordable rates,” the site’s ... reseller hosting is a very popular way for webmasters ...
(Date:9/21/2014)... Dallas, TX (PRWEB) September 21, 2014 ... and Chinese Fenofibrate (CAS 49562-28-9) Industry, 2009-2019 ... on Global and Chinese Fenofibrate (CAS 49562-28-9) ... information of Fenofibrate (CAS 49562-28-9) including its ... explores global and China’s top manufacturers of ...
Breaking Medicine News(10 mins):Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Cancer cells adapt energy needs to spread illness to other organs 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 4Health News:Best Cheap Hosting USA Announces The Best Reseller Hosting Suppliers In 2014 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4
... According to the U.S. researchers, 80% accuracy in prediction of ... is achieved by a new test that examines the// genetic ... researchers at Duke University in North Carolina report that this ... only a single drug against a particular cancer but also ...
... studies offers good news and bad news for women faced ... ,The good news is that screening mammography does reduce ... mammograms are 15 percent less likely to die of breast ... ,The bad news is that women in a screened population ...
... are at increased risk of burnout, which seems ... depression, reports a study in the// October Journal ... the American College of Occupational and Environmental Medicine ... of the Finnish Institute of Occupational Health, Helsinki ...
... technical university preparing engineers and other professionals, female foeticide ... take up but the Punjab Technical University (PTU) is ... social issues. // ,The campaign by PTU gets ... and Technology (SVIET) at Banur, 25 km from here. ...
... has always been considered as a 'pleasure chemical,' in charge ... extols a person or animal for the continuous activity that ... certain drugs like cocaine and heroin can simply intensify this ... the University of Michigan adds a new twist to dopamine's ...
... Pharmaceuticals Corporation, Zaditor? (ketotifen fumarate ophthalmic solution 0.025%), ... due to allergic conjunctivitis has been endorsed by ... over-the-counter use. Eye allergies affect around 40 million ... to seasonal allergens like pollen and ragweed, or ...
Cached Medicine News:Health News:Genomic tests for better cancer treatment 2Health News:Mammograms Reduce Breast Cancer Deaths, But Increase Overdiagnosis 2Health News:Mammograms Reduce Breast Cancer Deaths, But Increase Overdiagnosis 3Health News:Mammograms Reduce Breast Cancer Deaths, But Increase Overdiagnosis 4Health News:Burnout Explains Link Between Job Strain and Depression 2Health News:Zaditor? - over-the-counter drug for itchy eyes 2
... Design Holds The Lens Securely During ... Blades Keep The Optic From Being ... Over Release Of The Optic.,Wide Jaw ... During Insertion.,Reusable, Autoclaveable, Made In The ...
... Unique In-Line Footplates Are Turned 90 ... The Diamond Blade While Incising Tissue. ,Special ... Blade Depth Penetration.,Pre-Set Blade Extension Settings ... Retraction And Full Extension.,1mm Wide Snub ...
2.5V Halogen source, fiber-optic delivery, 2.5X magnification....
Pocket-sized instrument with 2.5X magnification....
Medicine Products: